Paramount Bed dividend yield – PARAMOUNT BED Holding Co Ltd Announces 31.0 Cash Dividend
March 18, 2023
PARAMOUNT BED ($TSE:7817) Holding Co Ltd recently announced a 31.0 Cash Dividend on March 1, 2023. The company has a history of paying a good dividend, with the annual dividend per share being 57.0, 55.0 and 50.0 JPY in the past 3 years, which have resulted in dividend yields of 2.78%, 2.67% and 2.21%, respectively, and an average dividend yield of 2.55%. The ex-dividend date for 2023 is set for March 30. If you are looking for a dividend stock to add to your investment portfolio, PARAMOUNT BED may be a good option. This company has a solid track record of delivering steady dividends, making it a reliable and profitable choice.
Moreover, the current 31.0 dividend provides investors with a healthy return on their investments. Investors should be aware that while dividend stocks are beneficial in many ways, they can also be subject to stock market volatility and economic cycles, as well as unpredictable changes in company policies and performance. Therefore, it is important to research a company before investing in order to understand their financial standing and the potential risks associated with their stocks.
The dividend will be paid out in the near future, although a specific date has yet to be determined. On Wednesday, the company’s stock opened at JP¥2361.0 and closed at JP¥2372.0, a decrease of 0.5% from its prior closing price of JP¥2383.0. Live Quote…
About the Company
Below shows the total revenue, net income and net margin for Paramount Bed. More…
|Total Revenues||Net Income||Net Margin|
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Paramount Bed. More…
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Paramount Bed. More…
|Total Assets||Total Liabilities||Book Value Per Share|
Key Ratios Snapshot
Some of the financial key ratios for Paramount Bed are shown below. More…
|3Y Rev Growth||3Y Operating Profit Growth||Operating Margin|
GoodWhale recently conducted a financial analysis of PARAMOUNT BED, and the results are in. According to Star Chart, PARAMOUNT BED is classified as ‘rhino’, a type of company we conclude that has achieved moderate revenue or earnings growth. Given the company’s strong health score of 10/10 due to its ability to pay off debt and fund future operations, as well as its strong assets, dividends, and profitability, this type of company may be attractive to many different investors. PARAMOUNT BED’s growth scores are weaker relative to other areas, but its overall performance is still impressive. Overall, PARAMOUNT BED is a solid investment opportunity and one that could be attractive to many types of investors. Its strong balance sheet, dividend payouts and profitability make it a safe bet in an uncertain market. Those seeking steady, moderate returns may find PARAMOUNT BED to be an ideal choice. More…
The competition between Paramount Bed Holding Co Ltd and its competitors, ConvaTec Group PLC, Coloplast A/S, and Airway Medix SA, is fierce. All four companies are vying for market share in the medical bed and equipment industry, offering a variety of products and services that seek to improve patient care. With the potential to have a direct impact on the health of those being served, each company is striving to outdo the other in order to gain a competitive edge.
– ConvaTec Group PLC ($LSE:CTEC)
ConvaTec Group PLC is a global medical technology company with a focus on developing, manufacturing, and marketing innovative products for the care of people living with chronic conditions. The company has a market capitalization of 4.63B as of 2023, indicating a strong presence and value in the medical technology sector. Additionally, ConvaTec Group PLC has an impressive Return on Equity of 4.96%, indicating the company is efficient in utilizing their capital to generate income.
– Coloplast A/S ($OTCPK:CLPBY)
Coloplast A/S is a Danish company that specializes in medical devices for wound care, ostomy care, continence care, and urology care. The company’s market cap of 24.03B reflects its strong financial performance for the year 2023. Coloplast A/S has a Return on Equity of 55.34%, which is indicative of its strong financial management and healthy balance sheet. Additionally, the company’s strong market cap reflects its strong presence in the medical device industry and its ability to generate sustainable returns for shareholders.
– Airway Medix SA ($LTS:0RI2)
Airway Medix SA is a healthcare company specializing in the development, manufacturing and distribution of inhalation and nebulization devices. With a market capitalization of 18.28M as of 2023, Airway Medix SA has been able to secure a strong standing in the healthcare industry. Furthermore, the company’s Return on Equity (ROE) stands at 9.07%, which is a strong indication of their financial health. This also demonstrates the company’s ability to generate consistent returns for its shareholders.
PARAMOUNT BED is a dividend stock with an average dividend yield of 2.55% over the past three years. Its annual dividend per share has been 57.0 JPY, 55.0 JPY and 50.0 JPY during this period. It has provided consistent dividend income to its shareholders.
This stock could be an attractive option for investors who are looking for a steady income while they wait for capital appreciation. Furthermore, since the dividend yield of PARAMOUNT BED over the past three years has been relatively stable, it could be a relatively safe and reliable dividend stock to add to one’s portfolio.
Leave a Comment